πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 38 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12343321

Method for ameliorating or avoiding the adverse effects of exogenous gonadotropins on repr

China Agricultural University Β· Granted Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11713324

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11654182

Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of

Rani Therapeutics, LLC Β· Granted Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11530239

Methods and compositions for treating diseases and conditions associated with gonadotropin

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10975124

Methods and compositions for treating diseases and conditions associated with gonadotropin

The Board of Regents of the University of Oklahoma Β· Granted Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10941159

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10864254

Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of

Rani Therapeutics, LLC Β· Granted Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10336769

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10322167

Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of

Rani Therapeutics, LLC Β· Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9808510

Method for delivering gonadotropin releasing hormone into a lumen of the intestinal tract

Rani Therapeutics, LLC Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9422310

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8952161

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8507536

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8481738

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8263588

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8084614

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7687610

Human chorionic gonadotropin superagonists

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7462625

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7419983

Gonadotropin-releasing hormone receptor antagonists and methods related thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7329669

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7229995

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7179815

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7176211

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7081459

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted